NetworkNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Provides Status Update on Pre-Commercial “LX Analyzer”
LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today provided a status update on the previously announced placement of its pre-commercial “LX Analyzer.” According to the update, the instrument LexaGene placed in a major U.S. hospital laboratory was configured to screen for COVID-19 and seven other respiratory pathogens. The company’s technology performs highly multiplex “RT-PCR,” which is a gold-standard chemistry that provides exceptional sensitivity and specificity. “These have been very exciting times for LexaGene where the device has been put into the field for testing of a…







